Abbott Laboratories (Germany) Insiders
| ABL Stock | 112.04 1.16 1.05% |
Abbott Laboratories employs about 115 K people. The company is managed by 10 executives with a total tenure of roughly 268334 years, averaging almost 26833.0 years of service per executive, having 11500.0 employees per reported executive. Breaking down Abbott Laboratories' management performance can provide insight into the firm performance.
| Scott Leinenweber Insider Licensing Relations |
| Robert Ford Insider Pres Chairman |
Abbott |
Abbott Laboratories Management Team Effectiveness
The company has return on total asset (ROA) of 0.0738 % which means that it generated a profit of $0.0738 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1901 %, meaning that it generated $0.1901 on every $100 dollars invested by stockholders. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Abbott Laboratories Workforce Comparison
Abbott Laboratories is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 122,580. Abbott Laboratories totals roughly 115,000 in number of employees claiming about 94% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. Abbott Laboratories Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Abbott Laboratories Price Series Summation is a cross summation of Abbott Laboratories price series and its benchmark/peer.
Abbott Laboratories Notable Stakeholders
An Abbott Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Abbott Laboratories often face trade-offs trying to please all of them. Abbott Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Abbott Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Scott Leinenweber | Licensing Relations | Profile | |
| Robert Ford | Pres Chairman | Profile | |
| James Young | VP Officer | Profile | |
| Elaine Leavenworth | VP Officer | Profile | |
| Mary Moreland | Ex HR | Profile | |
| Robert Funck | Exec CFO | Profile | |
| Daniel Salvadori | Ex Products | Profile | |
| Andrea Wainer | Ex Diagnostics | Profile | |
| Hubert Allen | Gen VP | Profile | |
| Melissa Brotz | VP Marketing | Profile |
About Abbott Laboratories Management Performance
The success or failure of an entity such as Abbott Laboratories often depends on how effective the management is. Abbott Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Abbott management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Abbott management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Abbott Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abbott Laboratories. Check Abbott Laboratories' Beneish M Score to see the likelihood of Abbott Laboratories' management manipulating its earnings.
Abbott Laboratories Workforce Analysis
Traditionally, organizations such as Abbott Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Abbott Laboratories within its industry.Abbott Laboratories Manpower Efficiency
Return on Abbott Laboratories Manpower
| Revenue Per Employee | 379.6K | |
| Revenue Per Executive | 4.4B | |
| Net Income Per Employee | 60.3K | |
| Net Income Per Executive | 693.3M |
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.